Results 51 to 60 of about 8,618 (210)

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome

Frontiers in Cardiovascular Medicine, 2021
Background: Recent studies have suggested that soluble suppression of tumorigenicity-2 (sST2), an inflammation-related protein receptor, is associated with atherosclerotic diseases.
Guqing Luo, Yuxuan Qian, Xincheng Sheng, Jiateng Sun, Zhinan Wu, Fei Liao, Qi Feng, Yan Yin, Song Ding, Jun Pu   +9 more
doaj   +1 more source

Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown.
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I. F. Oerlemans, Manon G. van der Meer, Nicolaas de Jonge, Anne‐Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W. Van Laake   +9 more
doaj   +1 more source

慢性阻塞性肺疾病患者血清IL-33、sST2、CRP水平与病情严重程度的相关性研究

Zhongguo shiyan zhenduanxue, 2021
目的探讨慢性阻塞性肺疾病(COPD)患者血清白介素33(IL-33)、可溶性生长刺激表达基因2蛋白(sST2)、C反应蛋白(CRP)与病情严重程度的相关性。方法收集南通市第二人民医院呼吸内科2019年1月-2020年10月期间COPD患者146例,检测并比较患者血清IL-33、sST2和CRP的变化,测定并计算COPD患者的FEV1占预计值百分比(FEV1%预计值),分析CRP、sST2、sST2/IL-33比值与FEV1%预计值的相关性。结果 COPD急性加重期(AECOPD)患者血清CRP ...
张曙晴, 张骆军, 周小林, 王玉蓉, 沈晓雯   +4 more
doaj  

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting

EJNMMI Research, 2020
Background Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for imaging and treatment of neuroendocrine tumors.
Rosalba Mansi, Karim Abid, Guillaume P. Nicolas, Luigi Del Pozzo, Eric Grouzmann, Melpomeni Fani   +5 more
doaj   +1 more source

Predictive value of soluble ST2 in adolescent and adult patients with complex congenital heart disease. [PDF]

PLoS ONE, 2018
BACKGROUND:Soluble suppression of tumorogenicity 2 (sST2) has been shown to be of prognostic value in patients with chronic and acute left heart failure.
Mohammed Laqqan, Christiane Schwaighofer, Stefan Graeber, Tanja Raedle-Hurst   +3 more
doaj   +1 more source

Galectin-3 and sST2 as Prognosticators for Heart Failure Requiring Extracorporeal Life Support: Jack n’ Jill

Biomolecules, 2021
Extracorporeal life support provides perfusion for patients with heart failure to allow time for recovery, function as a bridge for patients to heart transplantation, or serve as destination therapy for long term mechanical device support.
Jianli Bi, V. Garg, A. Yates
semanticscholar   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention

Journal of Interventional Cardiology, 2022
Background. Soluble growth stimulator gene 2 protein (sST2) is associated with heart failure and myocardial infarction; however, the predictive value of plasma sST2 level for coronary slow flow/no-reflow (CSF/NRF) is unclear.
Shu-min Chang, Yan-tan Yu, Bo Luan, Ai-jie Hou, Yong Wang   +4 more
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: a prospective observational study

BMC Geriatrics, 2021
Background Soluble suppression of tumorigenesis-2 (sST2) was reported to be associated with cognitive performance and risk of incident stroke. However, the impact of sST2 on cognitive function after ischemic stroke is unclear.
Yinwei Zhu, Chongquan Fang, Qi Zhang, Yaling Lu, Rui Zhang, Aili Wang, Xiaoqing Bu, Jintao Zhang, Zhong Ju, Yonghong Zhang, Tan Xu, Chongke Zhong   +11 more
doaj   +1 more source